Fans of the Toronto Maple Leafs have long paid emotionally for the team’s disappointments. Soon, they may get the chance to pay financially as well.
CME Group intends to launch futures tied to performance indexes for all 32 NHL teams on September 28, subject to regulatory review. Volatility Shares has filed with the U.S. Securities and Exchange Commission for 32 corresponding ETFs, including one for the Leafs. The filing is not yet effective.
The Leafs ETF would own no percentage of the team — no ticket revenue, broadcasting rights or piece of the franchise. Its index starts each season at 7,500, moves with 55 measures of team performance and resets after the playoffs.
There is nothing inherently wrong with turning unusual risks into tradable instruments. A Toronto bar protecting itself against another early Leafs playoff exit has a business risk to hedge. A fan buying because this is finally the year is not hedging anything. That is a bet.
On August 27, Canadian regulators drew that line more clearly than before.
The Canadian Securities Administrators (CSA) and the Canadian Investment Regulatory Organization (CIRO) said sports and entertainment event contracts should not be regulated within securities and derivatives legislation. CIRO added that it does not consider it appropriate to approve dealer applications to trade them.
That is not a hint. It is a policy choice. The proposed Leafs ETF tests whether that policy follows the economic exposure or stops at the legal form.
The sponsor says the fund does not invest in prediction markets or event contracts. Technically, that is right. It would hold futures tied to a continuously calculated team-performance index.
But the distinction is mechanical. The retail buyer is still taking a financial position on how the Leafs perform. CME itself says these futures are for fans as well as sponsors, broadcasters, arena operators and vendors. Business users may be hedging. Fans are not.
If the policy announced on August 27 can be avoided by inserting an index and a fund between the fan and the team, it is not much of a policy.
National Instrument 81-102 does not apply to a U.S.-listed ETF. But the counterfactual matters. Even a Canadian version would not necessarily be caught simply because the derivative references sports performance.
The rule restricts some classes of exposure when regulators choose to do so — real property, mortgages, precious metals, physical commodities and crypto assets among them. Sports performance is not on the list.
The new CSA-CIRO guidance on foreign-listed ETFs does not answer the substantive question either. It deals with disclosure, tax and currency treatment, manager registration and Canadian prospectus protections. Those are legitimate concerns. None asks whether the exposure itself belongs in a retail investment account.
The tax rules make the gap sharper. Except for certain derivatives, a security listed on a designated stock exchange is generally a qualified investment for registered plans, including ETF units. Futures and other derivatives are excluded when the holder’s potential loss can exceed the cost of the investment.
The Leafs ETF has not been approved or listed, so its qualified-investment status cannot yet be known. But if it lists on a designated U.S. exchange and otherwise meets the rules, the investor could hold the ETF in an RRSP even though the fund’s exposure comes from sports-performance futures.
That is not a trivial difference in packaging. It is a difference in where the product can sit and how it is treated.
Locker room insiders
There is also a market-integrity problem. The sponsor’s filing identifies the risk that team-connected people may know about injuries, scratches and lineup changes before the public. Equity markets have decades of insider-trading law. Sports-performance futures do not come with the same settled framework.
And there is a reason to care beyond regulatory tidiness. A recent National Bureau of Economic Research working paper describes sports betting, prediction markets and retail options trading as converging markets. The products are still different. Increasingly, the experience is not.
The paper contrasts conventional investing, where risky assets offer positive expected returns over time, with retail betting markets that are zero-sum before costs, and negative-sum after them.
That matters when the same brokerage screen can hold retirement savings, options, event contracts and a Leafs ETF. The labels differ. The money comes from the same household.
Canadian regulators do not need another debate about whether sports wagers belong in investment accounts. They have now said they do not.
They need to apply that judgment consistently. A sports-performance product should not receive a different retail outcome merely because its exposure travels through an index, a futures contract and an ETF. If regulators mean what they said on August 27, the economic substance must matter more than the wrapper.
Dealers need not wait. A U.S. ticker is not an instruction to put a product on a Canadian retail shelf. Product review should look through the structure and ask what the client is buying.
Advisors have the easiest call. A client may want to speculate on the Leafs. Fine. Client enthusiasm does not turn fandom into an investment objective.
Bet on the Leafs if you like. Just do not let a brokerage account make it look like retirement planning.
